Emergent Biosolutions Inc (EBS)
NYSE
The current EBS market cap is 326.12M. The company's latest EPS is USD -14.3744 and P/E is -0.43.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 165.1M | 337.9M | 269.7M | 276.6M | 300.4M |
Operating Income | -148.1M | 13.8M | -548.3M | -73.7M | 39.8M |
Net Income | -183M | -261.3M | -266.7M | -49.5M | 9M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.11B | 1.56B | 1.79B | 1.12B | 1.05B |
Operating Income | 114.1M | 433.8M | 352.6M | -172.7M | -726.4M |
Net Income | 54.5M | 305.1M | 230.9M | -223.8M | -760.5M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2.95B | 2.18B | 1.89B | 1.82B | 1.8B |
Total Liabilities | 1.75B | 1.22B | 1.2B | 1.17B | 1.14B |
Total Equity | 1.2B | 956.3M | 697.2M | 649.3M | 663.9M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2.33B | 2.88B | 2.96B | 3.17B | 1.82B |
Total Liabilities | 1.24B | 1.44B | 1.34B | 1.78B | 1.17B |
Total Equity | 1.09B | 1.45B | 1.62B | 1.38B | 649.3M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -184M | -298.4M | -238.4M | -206.3M | -62.6M |
Investing | -15.1M | 242.6M | 223.7M | 212.3M | -10.8M |
Financing | -10.5M | -497.4M | -540.4M | -535.7M | 40.7M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 188M | 536M | 321.1M | -34.1M | -206.3M |
Investing | -96.9M | -151M | -225M | -381.3M | 212.3M |
Financing | -35.9M | 69.5M | -141M | 481.2M | -535.7M |
Market Cap | 326.12M |
Price to Earnings Ratio | -0.43 |
Price to Sales Ratio | 0.31 |
Price to Cash Ratio | 2.94 |
Price to Book Ratio | 0.51 |
Dividend Yield | - |
Shares Outstanding | 52.91M |
Average Volume (1 week) | 2.04M |
Average Volume (1 Month) | 2.19M |
52 Week Change | 90.84% |
52 Week High | 15.10 |
52 Week Low | 1.42 |
Spread (Intraday) | 0.02 (0.32%) |
Company Name | Emergent Biosolutions Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.emergentbiosolutions.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.